• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter








Results

Number of results: 6

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Develop and Implement Revised CDRH Honor Awards ProcessCDRHOffice of Management OperationsCDRH Strategic PlanStrengthen Our Workforce and Workplace
2Develop a CDRH Employee Resource CenterCDRHOffice of Communication, Education and Radiation ProgramsCDRH Strategic PlanStrengthen Our Workforce and Workplace
3Medical Device Single Audit Program (MDSAP)CDRHOffice of ComplianceCDRH Strategic PlanDevices are Legally Marketed in the U.S. and Remain Safe, Effective, and of High-Quality
4Improving the Use of Computational Fluid Dynamic (CFD) Techniques to Evaluate Performance and Blood Damage Safety in Medical DevicesCDRHOffice of Science and Engineering LaboratoriesCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
5Unique Device Identification Database (UDID)CDRHOffice of Surveillance and BiometricsCDRH Strategic PlanFully Implement a Total Product Life Cycle Approach
6Personalized MedicineCDRHOffice of In Vitro Diagnostics and Radiological HealthCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.